U.S. flag

An official website of the United States government

NM_000744.7(CHRNA4):c.544T>C (p.Trp182Arg) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 29, 2012
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000186925.1

Allele description [Variation Report for NM_000744.7(CHRNA4):c.544T>C (p.Trp182Arg)]

NM_000744.7(CHRNA4):c.544T>C (p.Trp182Arg)

Gene:
CHRNA4:cholinergic receptor nicotinic alpha 4 subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q13.33
Genomic location:
Preferred name:
NM_000744.7(CHRNA4):c.544T>C (p.Trp182Arg)
Other names:
p.W182R:TGG>CGG
HGVS:
  • NC_000020.11:g.63350867A>G
  • NG_011931.1:g.15477T>C
  • NM_000744.7:c.544T>CMANE SELECT
  • NM_001256573.2:c.16T>C
  • NP_000735.1:p.Trp182Arg
  • NP_001243502.1:p.Trp6Arg
  • NC_000020.10:g.61982219A>G
  • NM_000744.5:c.544T>C
  • NR_046317.2:n.753T>C
Protein change:
W182R
Links:
dbSNP: rs796052317
NCBI 1000 Genomes Browser:
rs796052317
Molecular consequence:
  • NM_000744.7:c.544T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256573.2:c.16T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_046317.2:n.753T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000240496GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Aug 29, 2012)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000240496.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Trp182Arg (TGG>CGG):c.544 T>C in exon 5 of the CHRNA4 gene (NM_000744.5)The Trp182Arg missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Project has not identified Trp182Arg in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as an uncharged, non-polar Tryptophan residue is replaced by a positively charged Arginine residue. Trp182Arg alters a highly conserved position in the protein, and multiple in silico algorithms predict it is likely disease-causing. However, the Trp182Arg substitution does not occur within the transmembrane region of the protein, where pathogenic missense mutations have been identified (Steinlein et al., 2010). Therefore, based on the currently available information, Trp182Arg is a strong candidate for a disease-causing mutation, but the possibility that it is a benign variant cannot be excluded. The variant is found in EPILEPSY panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022